- Research article
- Open Access
Metabolomics analysis of serum in a rat heroin self-administration model undergoing reinforcement based on 1H-nuclear magnetic resonance spectra
© The Author(s) 2018
- Received: 7 January 2017
- Accepted: 3 February 2018
- Published: 5 March 2018
Understanding the process of relapse to abused drugs and ultimately developing treatments that can reduce the incidence of relapse remains the primary goal for the study of substance dependence. Therefore, exploring the metabolite characteristics during the relapse stage is valuable.
A heroin self-administered rat model was employed, and analysis of the 1H-nuclear magnetic resonance-based metabolomics was performed to investigate the characteristic metabolite profile upon reintroduction to the drug after abstinence.
Sixteen metabolites in the serum of rats, including phospholipids, intermediates in TCA (Tricarboxylic Acid Cycle) cycle, keto bodies, and precursors for neurotransmitters, underwent a significant change in the reinstatement stage compared with those in the control group. In particular, energy production was greatly disturbed as evidenced by different aspects such as an increase in glucose and decrease in intermediates of glycolysis and the TCA cycle. The finding that the level of 3-hydroxybutyrate and acetoacetate increased significantly suggested that energy production was activated from fatty acids. The concentration of phenylalanine, glutamine, and choline, the precursors of major neurotransmitters, increased during the reinstatement stage which indicated that an alteration in neurotransmitters in the brain might occur along with the disturbance in substrate supply in the circulatory system.
Heroin reinforcement resulted in impaired energy production via different pathways, including glycolysis, the TCA cycle, keto body metabolism, etc. A disturbance in the substrate supply in the circulatory system may partly explain heroin toxicity in the central nervous system. These findings provide new insight into the mechanism underlying the relapse to heroin use.
- Heroin self-administration
- 1H-nuclear magnetic resonance
In general, drug addiction is defined as compulsive, out-of-control drug use, despite negative consequence. It is well known to encompass several behavioral stages: intoxication, bingeing, craving and withdrawal . The dependence potential of a drug varies from substance to substance, and from individual to individual. An article in The Lancet compared the harm and dependence liability of 20 drugs, using a scale from zero to three for physical dependence, psychological dependence, and pleasure to create a mean score for dependence. Of the 20 drugs, the score for heroin for all three separate parameters was the highest that is, three which is why heroin has been called the most addictive drug .
Heroin (diacetylmorphine) is an opioid. Heroin use in the general population increased from 373,000 in 2007 to 914,000 in 2014 worldwide (http://www.samhsa.gov/). While there are varying regional trends in the extent of illicit drug use, the overall global prevalence of drug use is considered to be stable. In China, there were 2.3 million drug users as of the end of 2015, and the percentage of opioid abusers was more than 40% (China National Narcotic Control Committee, Annual review of drug situation in China, 2015).
Although many pharmacological treatments for heroin addiction have been established to ease craving and other physical symptoms, the effectiveness of these treatments has remained obscure . Furthermore, the complicated neurobiological changes accompanying the molecular mechanism leading to drug addiction are not known in detail. Thus, a “global” qualitative and quantitative method will help to provide a complete picture that directly reflects the physiological alterations in the body fluid when person becomes addicted to drugs or is undergoing withdrawal symptoms. Given that the overall health status of an individual is captured by his or her metabolic state, which is a reflection of what has been encoded by the genome and modified by environmental factor, metabolomics has the potential to have a greater impact upon medical practice by providing a wealth of relevant biochemical data compared with that provided by genomics, transcriptomics or proteomics .
Metabolomics involves the study of the repertoire of small molecules, or metabolites present in a cell, tissue, organ, or biological fluid. A wide variety of methods have been used to separate and quantify components of the metabolome, and no single analytical platform can capture all metabolomic information in a sample . Liquid and gas chromatography-mass spectrometry, nuclear magnetic resonance (NMR) spectroscopy, and liquid chromatography with electrochemical detection are all used. Overall, NMR is a nondestructive technique and in spite of the overlapping chemical shifts for some metabolites it is generally highly effective for structural elucidation .
Animal models involving drug self-administration (SA), conditioned place preference (CPP), and drug discrimination paradigms, have been developed to study specific aspects of drug addiction and substance abuse disorders . Compared with that provided by other models of addiction, SA provides the most direct point-to-point correspondence with addictive behavior that occurs in the natural environment. For this reason, SA has a high degree of face validity . Typically, a drug SA paradigm involves acquisition, extinction or abstinence and reinforcement. Different types of treatments have been found to induce reinforcement, and each of them is clearly analogous to the events that can trigger relapse in human drug abusers. In clinical practice, the risk of relapse remains high even after completion of treatment and prolonged abstinence. Therefore, understanding the vulnerability to relapse is crucial for the development of an effective treatment for drug addiction.
Recently, many studies have applied the metabolomics platform to find molecular markers for drug dependence and some results have been obtained [9–11]. However, none of these studies utilized the SA model, whereas the CPP model has been widely used. In addition, few studies have encompassed the metabolomics data during the reinstatement stage. Although brain tissue and cerebrospinal fluid are obvious samples to use when searching for biomarkers in central nervous system (CNS) disease, the use of serum has some advantages. The most important is that the identification of serum biomarkers more easily translated into clinical use. In addition, there are many pieces of evidence suggesting that changes in the CNS might be correlated with changes in the periphery [12–14]. Thus, in this paper we used 1H-NMR-based metabolomics technology to analyze the serum metabolite profiling of rats after reinstatement.
Representative 1H-600 MHz NMR spectra of the serum in a heroin SA rat showing the most representative metabolites identified in this sample are shown in Additional file 1: Fig. S1. Good quality spectra, characterized by the presence of signals with varying degrees of overlap, were obtained for most of the samples. The metabolites observed in the 1H-NMR spectra of serum were mainly associated with amino acids (tyrosine, alanine, valine/leucine/isoleucine, histidine, phenylalanine, lysine, glutamate), energy metabolism (α-glucose, succinate, pyruvate), keto body metabolism (acetone, acetoacetate, 3-hydroxybutyrate), and membrane metabolites (phosphocholine, glycerol phosphocholine, lipid).
Relapse is considered a central characteristic of addiction and possibly the most important to overcome. A primary goal of these studies was to understand the human relapse process and, ultimately, to develop treatments that reduce the incidence of relapse. The reinstatement procedure was used to model relapse following a period of abstinence. In this study, reinforcement was induced by re-exposure to the self-administered drug, and the simulation was presumed to be analogous to the true state of a drug-abuser upon incidental exposure to the drug after abstinence. From the number of active-poke responses in Fig. 1, we can see that during the 9 sessions of training, the rats acquired a reliable heroin self-administration response since the active nose-poke response increased gradually and remained relatively stable during the last 3 days. After 14 sessions of abstinence, when the rats were induced by 1 mg/kg heroin, the active nose-poke response recovered to more than one hundred which indicated that the desire for the drug was primed again. We wanted to explore what occurred in the body during this critical status.
Serum metabolome modification with heroin self-administration
A complete segregation between the control and self-administration group was observed on the score plot of the PCA, PLS-DA, and OPLS-DA models, and different types of validation methods also demonstrated that the model was effective and reliable.
Sixteen out of 27 identified metabolites were significantly altered and five were down-regulated, while eleven were unregulated. Based on the KEGG pathway analysis, three interconnected pathways were disturbed. Glycerol-3-phospho choline, phosphocholine, choline are the main metabolites that participate in phospholipid cycling, and pyruvate and fumarate are key intermediates in glycolysis and the TCA cycle, which is the central pathway for energy production, while 3-HB and acetoacetate are a part of the keto body pathway. Importantly, choline, glutamine, and phenylalanine are precursors of important neurotransmitters.
In our results, the concentrations of choline, phosphocholine and glycerol phosphocholine were elevated in the SA group. Changes in fatty acid levels in the blood have been correlated with relapse , supporting the hypothesis that blood lipids can serve as biomarkers of cocaine-induced neurological dysfunction. The hypothesis that blood lipids can be related to neurological dysfunction and behavior is further bolstered by a recent finding in Alzheimer’s patients demonstrating that select serum glycerol-phospholipids predicted cognitive impairment over 2–3 years with 90% accuracy . All of these results demonstrate that phospholipid profiling in serum may be a potential indication of cell membrane disruption in barrier function associated with drug-addiction.
Neuronal activity is extremely energy demanding, and the brain energy supply requires oxidative metabolism of glucose in mitochondria and demands lactic acid from glycolytic processes. In our results, we observed a disturbance in metabolites including α-glucose, pyruvate, which is involved in glycolysis, fumarate, a key intermediate in the TCA cycle, and lactate, which participates in energy production through a different pathway. Numerous papers have revealed a disturbance in energy metabolism by drug abuse [19, 20]. Zheng et al. reported that intermediates of the TCA were elevated after heroin administration and even after heroin withdrawal for 4 days, indicating an upregulation of the TCA cycle for increased energy metabolism and supply. These data suggest that heroin accelerated energy metabolism and produced more ATP during the acquisition and withdrawal stage . However, during the relapse stage, the concentration of fumarate and lactate also decreased which is consistent with our results. These results imply that the energy supply during the acquisition stage, the withdrawal stage and the relapse stage is different. Therefore, extra attention should be paid to the effective treatment of drug addiction.
Glucose, a primary energy substance for brain metabolism, plays an important role in energy homeostasis. Several studies have been performed to investigate the influence of drug abuse on blood glucose levels [22, 23]. Li et al. reported that nicotine priming induced an increase in glucose in the striatum . The increase in plasma glucose induced by administration of methamphetamine (MA) suggested that administration of MA inhibited the production of energy by glycolysis . Thus, these findings combined with our results have revealed that different types of abused drugs can cause an increase in glucose in the blood or other tissues.
Lactate is deemed to supply alternate energy sources for the brain and could be associated with protective preconditioning. Meanwhile, lactate is metabolized through the TCA, and when compared to glucose, it is equivalent with regard to its access to the TCA in neurons . After a nicotine CPP paradigm, an increase in lactate was found in the NAc , while nicotine decreased the level of lactate in the NAc and striatum in another study . The reduced levels of lactate in the urine increased after heroin withdrawal . In our study, the levels of lactate in the serum decreased significantly during the relapse stage. This result together with the increase in glucose and decrease in pyruvate and fumarate in the serum explained the involvement of a different pathway in the disturbance in the energy production by heroin self-administration, which should be paid more attention to develop treatments that reduce the incidence of relapse.
Ketone bodies (3-hydroxybutyrate (3-HB), acetoacetate and acetone) serve as an energy source alternative to glucose for the brain . A change in 3-HB had also been reported to be induced by nicotine and MA administration [9, 24]. In our study, 3-HB and acetoacetate were upregulated in the serum. This result was in accordance with the aforementioned increase in glucose and decrease in pyruvate and fumarate. All of the results together indicated that during the reinstatement stage, heroin administration inhibited energy production by glycolysis and oxidative phosphorylation via the TCA cycle and activated ketogenesis in order to produce energy.
Moreover, we noticed that the body weight of the SA group decreased during the training process and recovered a little during abstinence (data not recorded). Therefore, the reduction in body weight might have contributed to the observed disturbance in energy metabolism. Nevertheless, most of heroin abusers lose weight, similar to the reduction observed in SA models. In the future, more dedicated studies are needed to reveal the relationship between heroin administration and energy metabolism.
Of the 16 changed metabolites in the serum, three are precursors of neurotransmitters, and their relative concentrations were elevated in the serum of the SA group. Choline, in combination with acetyl-CoA, is catalyzed by the enzyme choline acetyltransferase (CHAT) to produce acetylcholine (ACH). CHAT is the rate-limiting enzyme for the formation of ACH and synaptic levels of ACH are regulated by CHAT. Cholinergic neurons are involved in brain learning and reward function. Studies have shown that acute heroin treatment significantly increases the number of CHAT-positive cells in the nucleus accumbens shell , and another study demonstrated that cure-induced reinstatement was inhibited by physostigmine, an inhibitor of acetylcholinesterase, in the NAc . Together, these results could depict a pathway through which the level of choline in the blood regulates the function of cholinergic neurons and then influences heroin relapse behavior.
Phenylalanine is catalyzed to tyrosine by phenylalanine hydroxylase in the liver, and l-tyrosine enters through the blood–brain barrier and is then converted to l-DOPA (l-3,4-dihydroxyphenylalanine), which is subsequently converted into dopamine by the enzyme DOPA decarboxylase. An increase in dopamine transmission in the nucleus accumbens shell is characteristic of drug addiction , and dopamine receptor agonists and antagonists have been widely investigated as putative pharmacological therapies for addiction . The rate-limiting enzyme of dopamine formation is tyrosine hydroxylase (TH). Changes in TH levels in the mesolimbic pathway have been related to drug addiction, but different results have been obtained in each of the relevant studies [29–31].
The release of glutamine into the periphery may provide the most important mechanism for the removal of excess nitrogen from the brain. The glutamate-glutamine cycle between astrocytes and neurons is well characterized . Aminobutyric acid (GABA), the chief inhibitory neurotransmitter is synthesized in the brain from glutamate using the enzyme glutamate decarboxylase (GAD). GABA and glutamate are involved in memory, learning and synaptic plasticity, and they are modulated by drugs of abuse . Glutamine not only serves as the precursor of the neurotransmitters but also plays an important role in energy production. The psychotropic effects of heroin on neurotransmitters and the nervous system are well known. Our result that the upregulation of these three metabolites in the serum indicated that a disturbance in the substrate supply in the circulatory system could perhaps partly explain heroin toxicity in the central nervous system. To validate this hypothesis, immunohistochemistry using specific brain tissue should be done to test the expression level of several critical enzymes including CHAT, GAD, and TH. Moreover, as NMR-based metabolomics analysis is more quantitative than qualitative, a fine quantification using a standard should be carried out to confirm the change in the three precursors of the neurotransmitters.
Opioids are known to interfere with normal gastrointestinal (GI) motility by delaying transit, resulting in adverse effects such as bowel dysfunction . These effects are primarily mediated by peripheral μ-opioid receptors, which are widely distributed in the submucosa . The slowed GI motility disturbs the profiling of metabolites in the serum. In addition, heroin administration leads to an alteration in gut microbiota , and gut microbiota can in turn impact serum metabolites. Therefore, more well designed studies are needed to verify whether the observed changes in metabolites were caused by heroin reinforcement directly or were an indirect result mediated by gut motility/gut microbiota.
In the present study, metabolite profiling in the serum of heroin self-administered rats that underwent reinforcement was analyzed using 1H NMR-based metabolomics. Our results suggest that heroin reinforcement resulted in impaired energy production via different pathways, including glycolysis, the TCA cycle, and keto body metabolism. The cell membrane metabolism was also disturbed. More importantly, the concentration of choline, phenylalanine and glutamine, the precursors of different dominant neurotransmitters, were upregulated in the blood, and this finding provides new insight into the mechanism through which drug abuse results in toxicity in the central nervous system.
Male Sprague–Dawley rats (260 ± 20 g) obtained from the Vital River Laboratory Animal Technology Co. Ltd (SCXK-2012-001) were housed individually in home cages in a temperature-controlled ventilated room with a reversed 12-h light/dark cycle (lights onset 08:00 p.m., offset 08:00 a.m.). Food and water were freely available. All procedures involving animals and their care were carried out according to the governmental guidelines on animal experimentation, National Institutes of Health “Principles of Laboratory Animal Care” and the Guide for the Care and Use of Laboratory Animals. The experiment was approved by Jianghan university experimental animal ethical review committee and the approval number is 201608002.
Chemicals and drugs
Diacetylmorphine hydrochloride (heroin) was obtained from the Hubei Public Security Bureau and was dissolved in 0.9% NaCl.
The rats (n = 20) received catheter surgery under anesthetization with sodium pentobarbital (50 mg/kg, i.p.). A silicon catheter (3.5 cm in length, 0.58 mm inner diameter, 0.91 mm outer diameter; BPU-30, Instech, Plymouth Meeting, PA, USA) was implanted and secured within the right jugular vein. The other end of the catheter (10 cm, PE20) was passed subcutaneously to the back and exited into a fluid-connector. Following surgery, each rat was housed individually in its cage and received a daily intravenous infusion of gentamicin (0.16 mg/kg) followed by 0.2 ml of a heparinized (1%) sterile saline solution to maintain catheter patency.
After 1 week of recovery, twelve rats were trained to self-administer heroin during daily 4-h sessions under a fixed ratio 1 schedule of reinforcement until stable responses occurred. Rats received a single heroin infusion (0.06 mg/kg) following an active nose-poke response. Each infusion was paired with a 5 s illumination of a light in combination with the noise of the infusion pump. Following each infusion, a time-out period was imposed for 20 s, during which responding was recorded but had no programmed consequences. After the timeout period, the red house light once again turned on, and a new self-administration training session started. Rats were put pack into their individual home cages shortly after the session. The rats continued SA training until stable responses occurred. The responses were considered stable when two criteria were met: 1) the number of active nose-poke responses was significantly more than the number of inactive nose-poke responses (p < 0.05); 2) less than 10% variability was obtained in the number of active nose–poke responses for at least three consecutive days. Rats meeting the acquisition criterion entered into a spontaneous abstinence session. All animals were kept in their home cage during the 14 days of abstinence. Then, drug-induced reinforcement was tested. All rats were injected with 1 mg/kg heroin (i.p.) and then placed into the operant chamber for 4 h, during which time the nose pokes had no programmed consequences, but the number of nose-poke responses were recorded. After the reinforcement test, blood was collected from the orbital sinus under chloral hydrate anesthesia. Serum samples were prepared and frozen in liquid nitrogen immediately after collection and stored at − 80 °C until analysis. The remaining eight rats comprised the control group and remained in their home cage after surgery throughout the operant process, and serum samples were collected at the same time and in the same way as for the SA group.
Prior to the metabolomics experiment, the serum samples were thawed at room temperature and vortexed. Next, mixtures of 200 μL of serum and 400 μL of saline solution (prepared from 0.9% NaCl, 15% D2O and 3 mM TSP) were mixed again. After centrifugation (10 min at 120,00g) an aliquot of 550 μL of each sample supernatant was subsequently transferred to a 5 mm NMR tube. The samples were maintained at 4 °C before measurement.
The NMR spectra of serum samples were recorded at 298 K using an Agilent Direct Drive2-600 MHz spectrometer (Agilent, USA) operating at a proton frequency of 599.83 MHz. The NMR spectra of the serum samples were recorded using a 1D CPMG pulse sequence with water presaturation in the Agilent notation. For each sample, 128 scans were collected with a spin-echo delay of 350 μs, 100 loops, relaxation delay of 2 s, acquisition time of 2.30 s, TD of 64 k, and SW of 16 ppm. Spectra were processed with a line broadening of 1 Hz and manually phased and baseline corrected using MestReNova 7.0 software (Mestrelab Research SL) and referenced to the α-glucose signal, δ = 5.23 ppm. The segments of δ 4.18–5.22 ppm and 5.4–6.0 ppm in spectra were removed to exclude the influence of the residual water and urea resonance. Each 1H-NMR spectrum over the range of δ 0.8–9.0 was integrated into an equal width (0.002 ppm). Each bucketed region was then normalized to the total sum of the spectral integrals to compensate for overall concentration differences.
Statistical data analysis
Prior to chemometrics analysis, the data set was Ctr scaled. For primary visualization, distribution and clustering, the principal component analysis (PCA) model was applied using SIMICA-P (V11.0, Umetrics AB, Umea, Sweden). Next, a PLS-DA with a sevenfold cross validation procedure (CV, 1/7 of the samples being excluded from calculations in each round) to determine the variation between data sets was adopted.
The concentration of the metabolites based on 1H NMR spectroscopy was calculated as the relative signal integrals of the non-overlapping resonances. The metabolite resonances were identified according to assignments published in the literature and in on-line databases (Human Metabolome Data Base, http://www.hmdb.ca/). The percentage difference was calculated based on the average values of relative signal integrals in each group. The OPLS-DA method was utilized to identify the differential metabolites between the two groups on Ctr-scaled data. Here, a correlation coefficient of |r| > 0.707 (df = 6) was used as the cut-off value that gave a statistically significant result at the level p < 0.05. To identify the most altered metabolic pathways, a set of significantly altered metabolites was used as the input for the KEGG Pathway Analysis.
TTN was responsible for the study concept and design. CLL and LC contributed to the acquisition of animal data. XKG and BMM constructed the self-administration animal model. TTN drafted the manuscript. All authors critically reviewed content and approved the final version for publication. All authors read and approved the final manuscript.
We thank Xing Yan at Wuhan Institute of Biotechnology, for his help with the NMR analysis. We also thank BioNovogene Company for its help with the data analysis. We are grateful to Chaoying Li at the Wuhan Institute of Biomedical Science, Jianghan University for his help in proof reading the article.
The authors declare that they have no competing interests.
Availability of data and materials
The data sets generated during the current study are available from the corresponding author on reasonable request.
Consent to publish
Ethics approval and consent to participate
All procedures involving animals and their care were carried out according to governmental guidelines on animal experimentation, namely, the National Institutes of Health’s “Principles of Laboratory Animal Care” and the “Guide for the Care and Use of Laboratory Animals”. The experiment was approved by Jianghan university experimental animal ethical review committee and the Approval Number is 201608002.
This work was supported by the Natural Science Foundation of Hubei Province (No. 2015CFB356).
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Cami J, Farre M. Drug addiction. N Engl J Med. 2003;349(10):975–86.View ArticlePubMedGoogle Scholar
- Nutt D, King LA, Saulsbury W, Blakemore C. Development of a rational scale to assess the harm of drugs of potential misuse. Lancet. 2007;369(9566):1047–53.View ArticlePubMedGoogle Scholar
- Bell J. Pharmacological maintenance treatments of opiate addiction. Br J Clin Pharmacol. 2014;77(2):253–63.View ArticlePubMedPubMed CentralGoogle Scholar
- Quinones MP, Kaddurah-Daouk R. Metabolomics tools for identifying biomarkers for neuropsychiatric diseases. Neurobiol Dis. 2009;35(2):165–76.View ArticlePubMedGoogle Scholar
- Dinis-Oliveira RJ. Metabolomics of drugs of abuse: a more realistic view of the toxicological complexity. Bioanalysis. 2014;6(23):3155–9.View ArticlePubMedGoogle Scholar
- Kaddurah-Daouk R, Kristal BS, Weinshilboum RM. Metabolomics: a global biochemical approach to drug response and disease. Annu Rev Pharmacol Toxicol. 2008;48:653–83.View ArticlePubMedGoogle Scholar
- Frascella J, Richardson KA, McLemore GL. Animal models of drug addiction in support of novel therapeutic strategies. ILAR J. 2011;52(3):233–8.View ArticlePubMedGoogle Scholar
- Panlilio LV, Goldberg SR. Self-administration of drugs in animals and humans as a model and an investigative tool. Addiction. 2007;102(12):1863–70.View ArticlePubMedPubMed CentralGoogle Scholar
- Li H, Chen B, Shao X, Hu Z, Deng Y, Zhu R, Li Y, Zhang B, Hou J, Du C, et al. 1H-Nuclear magnetic resonance-based metabolomic analysis of brain in mice with nicotine treatment. BMC Neurosci. 2014;15(1):32.View ArticlePubMedPubMed CentralGoogle Scholar
- Zaitsu K, Miyawaki I, Bando K, Horie H, Shima N, Katagi M, Tatsuno M, Bamba T, Sato T, Ishii A, et al. Metabolic profiling of urine and blood plasma in rat models of drug addiction on the basis of morphine, methamphetamine, and cocaine-induced conditioned place preference. Anal Bioanal Chem. 2014;406(5):1339–54.View ArticlePubMedGoogle Scholar
- Meng J, Zhang X, Wu H, Bu J, Shi C, Deng C, Mao Y. Morphine-induced conditioned place preference in mice: metabolomic profiling of brain tissue to find “molecular switch” of drug abuse by gas chromatography/mass spectrometry. Anal Chim Acta. 2012;710:125–30.View ArticlePubMedGoogle Scholar
- Leoni V, Masterman T, Patel P, Meaney S, Diczfalusy U, Bjorkhem I. Side chain oxidized oxysterols in cerebrospinal fluid and the integrity of blood-brain and blood-cerebrospinal fluid barriers. J Lipid Res. 2003;44(4):793–9.View ArticlePubMedGoogle Scholar
- Maier B, Laurer HL, Rose S, Buurman WA, Marzi I. Physiological levels of pro- and anti-inflammatory mediators in cerebrospinal fluid and plasma: a normative study. J Neurotrauma. 2005;22(7):822–35.View ArticlePubMedGoogle Scholar
- Obeid R, Kostopoulos P, Knapp JP, Kasoha M, Becker G, Fassbender K, Herrmann W. Biomarkers of folate and vitamin B12 are related in blood and cerebrospinal fluid. Clin Chem. 2007;53(2):326–33.View ArticlePubMedGoogle Scholar
- Zhang F, Zhou W, Liu H, Zhu H, Tang S, Lai M, Yang G. Increased c-Fos expression in the medial part of the lateral habenula during cue-evoked heroin-seeking in rats. Neurosci Lett. 2005;386(2):133–7.View ArticlePubMedGoogle Scholar
- Zhang F, Zhou W, Tang S, Lai M, Liu H, Yang G. Motivation of heroin-seeking elicited by drug-associated cues is related to total amount of heroin exposure during self-administration in rats. Pharmacol Biochem Behav. 2004;79(2):291–8.View ArticlePubMedGoogle Scholar
- Buydens-Branchey L, Branchey M, McMakin DL, Hibbeln JR. Polyunsaturated fatty acid status and relapse vulnerability in cocaine addicts. Psychiatry Res. 2003;120(1):29–35.View ArticlePubMedGoogle Scholar
- Mapstone M, Cheema AK, Fiandaca MS, Zhong X, Mhyre TR, MacArthur LH, Hall WJ, Fisher SG, Peterson DR, Haley JM, et al. Plasma phospholipids identify antecedent memory impairment in older adults. Nat Med. 2014;20(4):415–8.View ArticlePubMedPubMed CentralGoogle Scholar
- Kovacic P. Role of oxidative metabolites of cocaine in toxicity and addiction: oxidative stress and electron transfer. Med Hypotheses. 2005;64(2):350–6.View ArticlePubMedGoogle Scholar
- Sadakierska-Chudy A, Frankowska M, Filip M. Mitoepigenetics and drug addiction. Pharmacol Ther. 2014;144(2):226–33.View ArticlePubMedGoogle Scholar
- Zheng T, Liu L, Aa J, Wang G, Cao B, Li M, Shi J, Wang X, Zhao C, Gu R, et al. Metabolic phenotype of rats exposed to heroin and potential markers of heroin abuse. Drug Alcohol Depend. 2013;127(1–3):177–86.View ArticlePubMedGoogle Scholar
- Herring NR, Schaefer TL, Tang PH, Skelton MR, Lucot JP, Gudelsky GA, Vorhees CV, Williams MT. Comparison of time-dependent effects of (+)-methamphetamine or forced swim on monoamines, corticosterone, glucose, creatine, and creatinine in rats. BMC Neurosci. 2008;9:49.View ArticlePubMedPubMed CentralGoogle Scholar
- Li H, Bu Q, Chen B, Shao X, Hu Z, Deng P, Lv L, Deng Y, Zhu R, Li Y, et al. Mechanisms of metabonomic for a gateway drug: nicotine priming enhances behavioral response to cocaine with modification in energy metabolism and neurotransmitter level. PLoS ONE. 2014;9(1):e87040.View ArticlePubMedPubMed CentralGoogle Scholar
- Shima N, Miyawaki I, Bando K, Horie H, Zaitsu K, Katagi M, Bamba T, Tsuchihashi H, Fukusaki E. Influences of methamphetamine-induced acute intoxication on urinary and plasma metabolic profiles in the rat. Toxicology. 2011;287(1–3):29–37.View ArticlePubMedGoogle Scholar
- Morris AA. Cerebral ketone body metabolism. J Inherit Metab Dis. 2005;28(2):109–21.View ArticlePubMedGoogle Scholar
- Zhou W, Liu H, Zhang F, Tang S, Zhu H, Lai M, Kalivas PW. Role of acetylcholine transmission in nucleus accumbens and ventral tegmental area in heroin-seeking induced by conditioned cues. Neuroscience. 2007;144(4):1209–18.View ArticlePubMedGoogle Scholar
- Bassareo V, Musio P, Di Chiara G. Reciprocal responsiveness of nucleus accumbens shell and core dopamine to food- and drug-conditioned stimuli. Psychopharmacology. 2011;214(3):687–97.View ArticlePubMedGoogle Scholar
- Moreira FA, Dalley JW. Dopamine receptor partial agonists and addiction. Eur J Pharmacol. 2015;752:112–5.View ArticlePubMedGoogle Scholar
- Committee CNNC: Annual review of drug situation in China; 2015.Google Scholar
- Todtenkopf MS, De Leon KR, Stellar JR. Repeated cocaine treatment alters tyrosine hydroxylase in the rat nucleus accumbens. Brain Res Bull. 2000;52(5):407–11.View ArticlePubMedGoogle Scholar
- Licata SC, Pierce RC. Repeated cocaine injections have no influence on tyrosine hydroxylase activity in the rat nucleus accumbens core or shell. Brain Res. 2004;1012(1–2):119–26.View ArticlePubMedGoogle Scholar
- Tani H, Dulla CG, Farzampour Z, Taylor-Weiner A, Huguenard JR, Reimer RJ. A local glutamate-glutamine cycle sustains synaptic excitatory transmitter release. Neuron. 2014;81(4):888–900.View ArticlePubMedPubMed CentralGoogle Scholar
- Pinheiro PS, Mulle C. Presynaptic glutamate receptors: physiological functions and mechanisms of action. Nat Rev Neurosci. 2008;9(6):423–36.View ArticlePubMedGoogle Scholar
- Lee AA, Hasler WL. Opioids and GI motility-friend or foe? Curr Treat Opt Gastroenterol. 2016;14(4):478–94.View ArticleGoogle Scholar
- De Schepper HU, Cremonini F, Park MI, Camilleri M. Opioids and the gut: pharmacology and current clinical experience. Neurogastroenterol Motil. 2004;16(4):383–94.View ArticlePubMedGoogle Scholar
- Ning T, Gong X, Xie L, Ma B. Gut microbiota analysis in rats with methamphetamine-induced conditioned place preference. Front Microbiol. 2017;8:1620.View ArticlePubMedPubMed CentralGoogle Scholar